Generally, we confine ourselves to matters concerning the pharmaceutical industry. Every now and then, though, we tiptoe into related fields for a couple of reasons – there are overlapping regulatory issues or some of the biggest drugmakers also play in other sandboxes where their fortunes are affected. And so we thought it would be interesting to share a recent survey on how patient groups view device makers, which include Johnson & Johnson and Abbott Laboratories.
